NCT00001298View on ClinicalTrials.gov

A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

March 31, 1992

Study Completion Date

January 31, 2001

Conditions

Kidney Diseases

Interventions

DRUG

carboxypeptidase-G2

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH